NMSS reports clinical trial alert in Bradenton, FL and other cities nationwide Examiner.com The National Multiple Sclerosis Society (NMSS) announced a trial alert yesterday for the study of daclizumab high yield process (DAC HYP). The alert stated the study was being sponsored by Biogen Idec (makers of Avonex) and Abbott Biotherapeutics. |
